Product Specific References | - Whitt, M.A., Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods, 2010. 169(2): p. 365-74.
- Howell KA, Qiu X, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ,Shulenin S, Biggins JE, Douglas R, Enterlein SG, Turner HL, Pallesen J, Murin CD,He S, Kroeker A, Vu H, Herbert AS, Fusco ML, Nyakatura EK, Lai JR, Keck ZY, FoungSK, Saphire EO, Zeitlin L, Ward AB, Chandran K, Doranz BJ, Kobinger GP, Dye JM,Aman MJ. Antibody Treatment of Ebola and Sudan Virus Infection via a UniquelyExposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Rep. 2016 May17;15(7):1514-26. View Article
- Zhao X, Howell KA, He S, Brannan JM, Wec AZ, Davidson E, Turner HL, Chiang CI, Lei L, Fels JM, Vu H, Shulenin S, Turonis AN, Kuehne AI, Liu G, Ta M, Wang Y, Sundling C, Xiao Y, Spence JS, Doranz BJ, Holtsberg FW, Ward AB, Chandran K, Dye JM, Qiu X, Li Y, Aman MJ. Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. Cell. 2017 May 18;169(5):891-904.e15. View Article
- Salata C, Baritussio A, Munegato D, Calistri A, Ha HR, Bigler L, Fabris F,Parolin C, Palù G, Mirazimi A. Amiodarone and metabolite MDEA inhibit Ebola virusinfection by interfering with the viral entry process. Pathog Dis. 2015Jul;73(5). pii: ftv032. View Article
- Schmidt F, Weisblum Y, Muecksch F, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. Preprint. bioRxiv. 2020;2020.06.08.140871. Published 2020 Jun 9. View Article
- Luchsinger LL, Ransegnola B, Jin D, et al. Serological Analysis of New York City COVID19 Convalescent Plasma Donors. Preprint. medRxiv. 2020;2020.06.08.20124792. Published 2020 Jun 9. View Article
- Johnson MC, Lyddon TD, Suarez R, et al. Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein [published online ahead of print, 2020 Aug 11]. J Virol. 2020;JVI.01062-20. View Article
- Farzani TA, Chov A, Herschhorn A. A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. STAR Protoc. 2020 Dec 9;1(3):100209. View article
- Condor Capcha JM, Lambert G, Dykxhoorn DM, Salerno AG, Hare JM, Whitt MA, Pahwa S, Jayaweera DT, Shehadeh LA. Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Front Cardiovasc Med. 2021 Jan 15;7:618651. View article
- Sagara I, Woodford J, Dicko A, Zeguime A, Doucoure M, Kwan J, Zaidi I, Doritchamou J, Snow-Smith M, Alani N, Renn J, Kosik I, Holly J, Yewdell J, Esposito D, Sadtler K, Duffy P. SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali. medRxiv [Preprint]. 2021 Mar 12:2021.03.08.21252784. View article
- Sandoval DR, et al. The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. bioRxiv [Preprint]. 2021 Mar 26:2021.03.22.436522. View article
- Nie J, Li Q, Zhang L, Cao Y, Zhang Y, Li T, Wu J, Liu S, Zhang M, Zhao C, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Liu J, Liang H, Jiang T, Duan K, Yang X, Shen Y, Huang W, Wang Y. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov. 2021 Apr 6;7(1):21. View article
|